Skip to main content
Label
Press Release

ObvioHealth Ranked No. 962 on Inc. 5000’s List of Fastest Growing Private Companies

Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest-growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Download the PDF

‍NEW YORK - August 15, 2023 – Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Companies on the 2023 Inc. 5000 list are ranked according to percentage revenue growth from 2019 to 2022. During this time, ObvioHealth’s growth rate was more than 600 percent.

This ranking demonstrates ObvioHealth’s accelerating presence in the highly competitive decentralized clinical trials space. ObvioHealth recently launched ObvioGo®, its next-generation platform that has been built on a powerful and flexible tech stack to empower clinical science teams to generate stronger therapeutic evidence. Concurrently, ObvioHealth has formed a successful partnership with industry powerhouse Oracle Health Sciences to facilitate the capture and integration of multisource data into a consolidated source of truth.  

“We bring together not only the technology to help run more efficient trials but also the deep clinical expertise of our virtual site and scientific teams,” said Ivan Jarry, CEO of ObvioHealth. “To achieve this ranking—at a time when our sector is experiencing both economic and structural challenges—is evidence of our winning formula.”

For more information, visit www.obviohealth.com. 

‍

Press Release

ObvioHealth Ranked No. 962 on Inc. 5000’s List of Fastest Growing Private Companies

No items found.
The virtual research organization has been ranked on the list for the third consecutive year.
Download the PDF

‍NEW YORK - August 15, 2023 – Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Companies on the 2023 Inc. 5000 list are ranked according to percentage revenue growth from 2019 to 2022. During this time, ObvioHealth’s growth rate was more than 600 percent.

This ranking demonstrates ObvioHealth’s accelerating presence in the highly competitive decentralized clinical trials space. ObvioHealth recently launched ObvioGo®, its next-generation platform that has been built on a powerful and flexible tech stack to empower clinical science teams to generate stronger therapeutic evidence. Concurrently, ObvioHealth has formed a successful partnership with industry powerhouse Oracle Health Sciences to facilitate the capture and integration of multisource data into a consolidated source of truth.  

“We bring together not only the technology to help run more efficient trials but also the deep clinical expertise of our virtual site and scientific teams,” said Ivan Jarry, CEO of ObvioHealth. “To achieve this ranking—at a time when our sector is experiencing both economic and structural challenges—is evidence of our winning formula.”

For more information, visit www.obviohealth.com. 

‍

Press Release

ObvioHealth Ranked No. 962 on Inc. 5000’s List of Fastest Growing Private Companies

Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest-growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

No items found.
Download the PDF

‍NEW YORK - August 15, 2023 – Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Companies on the 2023 Inc. 5000 list are ranked according to percentage revenue growth from 2019 to 2022. During this time, ObvioHealth’s growth rate was more than 600 percent.

This ranking demonstrates ObvioHealth’s accelerating presence in the highly competitive decentralized clinical trials space. ObvioHealth recently launched ObvioGo®, its next-generation platform that has been built on a powerful and flexible tech stack to empower clinical science teams to generate stronger therapeutic evidence. Concurrently, ObvioHealth has formed a successful partnership with industry powerhouse Oracle Health Sciences to facilitate the capture and integration of multisource data into a consolidated source of truth.  

“We bring together not only the technology to help run more efficient trials but also the deep clinical expertise of our virtual site and scientific teams,” said Ivan Jarry, CEO of ObvioHealth. “To achieve this ranking—at a time when our sector is experiencing both economic and structural challenges—is evidence of our winning formula.”

For more information, visit www.obviohealth.com. 

‍

Press Release

ObvioHealth Ranked No. 962 on Inc. 5000’s List of Fastest Growing Private Companies

No items found.
Download the PDF

‍NEW YORK - August 15, 2023 – Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Companies on the 2023 Inc. 5000 list are ranked according to percentage revenue growth from 2019 to 2022. During this time, ObvioHealth’s growth rate was more than 600 percent.

This ranking demonstrates ObvioHealth’s accelerating presence in the highly competitive decentralized clinical trials space. ObvioHealth recently launched ObvioGo®, its next-generation platform that has been built on a powerful and flexible tech stack to empower clinical science teams to generate stronger therapeutic evidence. Concurrently, ObvioHealth has formed a successful partnership with industry powerhouse Oracle Health Sciences to facilitate the capture and integration of multisource data into a consolidated source of truth.  

“We bring together not only the technology to help run more efficient trials but also the deep clinical expertise of our virtual site and scientific teams,” said Ivan Jarry, CEO of ObvioHealth. “To achieve this ranking—at a time when our sector is experiencing both economic and structural challenges—is evidence of our winning formula.”

For more information, visit www.obviohealth.com. 

‍

Press Release

ObvioHealth Ranked No. 962 on Inc. 5000’s List of Fastest Growing Private Companies

No items found.
Download the PDF

‍NEW YORK - August 15, 2023 – Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Companies on the 2023 Inc. 5000 list are ranked according to percentage revenue growth from 2019 to 2022. During this time, ObvioHealth’s growth rate was more than 600 percent.

This ranking demonstrates ObvioHealth’s accelerating presence in the highly competitive decentralized clinical trials space. ObvioHealth recently launched ObvioGo®, its next-generation platform that has been built on a powerful and flexible tech stack to empower clinical science teams to generate stronger therapeutic evidence. Concurrently, ObvioHealth has formed a successful partnership with industry powerhouse Oracle Health Sciences to facilitate the capture and integration of multisource data into a consolidated source of truth.  

“We bring together not only the technology to help run more efficient trials but also the deep clinical expertise of our virtual site and scientific teams,” said Ivan Jarry, CEO of ObvioHealth. “To achieve this ranking—at a time when our sector is experiencing both economic and structural challenges—is evidence of our winning formula.”

For more information, visit www.obviohealth.com. 

‍

Press Release

ObvioHealth Ranked No. 962 on Inc. 5000’s List of Fastest Growing Private Companies

Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest-growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Download the PDF
No items found.

‍NEW YORK - August 15, 2023 – Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Companies on the 2023 Inc. 5000 list are ranked according to percentage revenue growth from 2019 to 2022. During this time, ObvioHealth’s growth rate was more than 600 percent.

This ranking demonstrates ObvioHealth’s accelerating presence in the highly competitive decentralized clinical trials space. ObvioHealth recently launched ObvioGo®, its next-generation platform that has been built on a powerful and flexible tech stack to empower clinical science teams to generate stronger therapeutic evidence. Concurrently, ObvioHealth has formed a successful partnership with industry powerhouse Oracle Health Sciences to facilitate the capture and integration of multisource data into a consolidated source of truth.  

“We bring together not only the technology to help run more efficient trials but also the deep clinical expertise of our virtual site and scientific teams,” said Ivan Jarry, CEO of ObvioHealth. “To achieve this ranking—at a time when our sector is experiencing both economic and structural challenges—is evidence of our winning formula.”

For more information, visit www.obviohealth.com. 

‍

Back to Top
Press Release

ObvioHealth Ranked No. 962 on Inc. 5000’s List of Fastest Growing Private Companies

Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest-growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Download the PDF

‍NEW YORK - August 15, 2023 – Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

Companies on the 2023 Inc. 5000 list are ranked according to percentage revenue growth from 2019 to 2022. During this time, ObvioHealth’s growth rate was more than 600 percent.

This ranking demonstrates ObvioHealth’s accelerating presence in the highly competitive decentralized clinical trials space. ObvioHealth recently launched ObvioGo®, its next-generation platform that has been built on a powerful and flexible tech stack to empower clinical science teams to generate stronger therapeutic evidence. Concurrently, ObvioHealth has formed a successful partnership with industry powerhouse Oracle Health Sciences to facilitate the capture and integration of multisource data into a consolidated source of truth.  

“We bring together not only the technology to help run more efficient trials but also the deep clinical expertise of our virtual site and scientific teams,” said Ivan Jarry, CEO of ObvioHealth. “To achieve this ranking—at a time when our sector is experiencing both economic and structural challenges—is evidence of our winning formula.”

For more information, visit www.obviohealth.com. 

‍

Discover More Case Studies

Discover More News

Discover More White Papers

Discover More Blogs

Discover More Playbooks

Discover More Webinars

Discover More Events

No items found.

ObvioHealth Welcomes Richard Watkins as Chief Revenue Officer at a Pivotal Moment of Transformation

ObvioHealth welcomes sales veteran Richard Watkins as CRO to guide the company’s shift to enterprise software. His proven leadership in SaaS and healthcare will help expand ObvioGo® 2.0’s impact on clinical trials worldwide.

› Read More
No items found.

ObvioHealth Announces the Appointment of Nicholas Campbell to Its Board of Directors

ObvioHealth announces the appointment of seasoned healthcare executive Nicholas Campbell to its Board of Directors. Campbell brings expertise to accelerate digital innovation and advance clinical trial solutions.

› Read More